The Burroughs Wellcome Fund is an independent private foundation dedicated to advancing the medical sciences by supporting research and oth...

The extremely stringent temperature requirement for mRNA vaccines, which is what the Pfizer vaccine candidate is based on, will also make i...

The ministry noted that symptomatic cases tested negative by RATs are not followed up by RT-PCR testing in some large states. The idea is t...

UK Department for Health has granted GBP 10 million funding for the hub that will be managed by the Engineering and Physical Sciences Resea...

The World Health Organisation estimates that there are nearly every year there are roughly 1.3 to 4 million cases Cholera cases globally an...

Kolkata, Dec 15 (IANS) The European Molecular Biology Organization (EMBO) and the Wellcome Trust/DBT India Alliance will partner to jointly...

A great deal is being made about the performance of Tata companies, but perhaps it's time for some scrutiny of the Trusts activities as wel...

Hilleman said it is looking to tie up with vaccine specialty companies and government agencies to fund a Rs 300 project for developing some...

Remidio Innovative Solutions was set up in 2010, with Rs 5 lakh from the promoters and two friends. It got Rs 15 lakh soon from IKP Knowled...

India may well be the place where the drug to fight the killer Ebola virus originates, with two drug candidates discovered in Bengaluru.

Some of the top executives, including the founding CEO, have moved on from Delhi-based vaccine research firm Hilleman Laboratories.

GEPL Capital has advised investors to ‘Subscribe’ to initial public offering of Muthoot Finance with a medium to long term perspective.

Ajcon Global has recommended clients to ‘Subscribe’ to the initial public offering of Muthoot Finance for listing gains.

An Indian healthcare JV between Merck & Co and Wellcome Trust plans to develop heat stable oral rotavirus vaccine to prevent diarrhoea in b...

As per the company's estimates, it will take 2-4 years in research and development activities to come out with the new vaccine.

Innovation, international partnerships, collaborations, inflow of funds, clinical trials partnerships and co-development deals are changing...

With the Indian pharmaceutical industry making rapid strides in the last few years, many observers are betting on the country becoming an a...